Emodin potentiates the anti-cancer effects of EGFR inhibitor on pancreatic cancer (PANC-1 and BxPC-3) cells by inhibiting STAT3 signaling, promoting apoptosis. Here, STAT3 is linked to pancreatic neoplasm.